Disulfide-Trapping Identifies a New, Effective Chemical Probe for Activating the Nuclear Receptor Human LRH-1 (NR5A2)

Autor: Elena P. Sablin, Miyuki Suzawa, John M. Bruning, Pamela M. England, Sam Irvy, Holly A. Ingraham, Felipe de Jesus Cortez, Matthew P. Jacobson, Robert J. Fletterick
Přispěvatelé: Lodola, Alessio
Jazyk: angličtina
Rok vydání: 2016
Předmět:
0301 basic medicine
Cytoplasmic and Nuclear
Carboxylic Acids
lcsh:Medicine
Receptors
Cytoplasmic and Nuclear

Ligands
Biochemistry
chemistry.chemical_compound
Binding Analysis
Receptors
Small interfering RNAs
Disulfides
Amino Acids
Receptor
lcsh:Science
Phospholipids
Multidisciplinary
Chemistry
Organic Compounds
Liver Disease
Hep G2 Cells
Lipids
Nucleic acids
Molecular Docking Simulation
5.1 Pharmaceuticals
Physical Sciences
Development of treatments and therapeutic interventions
Lead compound
Cell Binding Assay
Hydrophobic and Hydrophilic Interactions
Biotechnology
Research Article
Agonist
medicine.drug_class
General Science & Technology
Library Screening
Research and Analysis Methods
03 medical and health sciences
Thiols
In vivo
medicine
Genetics
Sulfur Containing Amino Acids
Humans
Cysteine
Molecular Biology Techniques
Non-coding RNA
Molecular Biology
Chemical Characterization
Virtual screening
Molecular Biology Assays and Analysis Techniques
Liver receptor homolog-1
lcsh:R
Organic Chemistry
Chemical Compounds
Biology and Life Sciences
Proteins
Amides
Gene regulation
030104 developmental biology
Nuclear receptor
Molecular Probes
RNA
lcsh:Q
Gene expression
Digestive Diseases
Acids
Zdroj: PLoS ONE
Cortez, FDJ; Suzawa, M; Irvy, S; Bruning, JM; Sablin, E; Jacobson, MP; et al.(2016). Disulfide-Trapping Identifies a New, Effective Chemical Probe for Activating the Nuclear Receptor Human LRH-1 (NR5A2). PLOS ONE, 11(7). doi: 10.1371/journal.pone.0159316. UC San Francisco: Retrieved from: http://www.escholarship.org/uc/item/2bp084k5
PloS one, vol 11, iss 7
PLoS ONE, Vol 11, Iss 7, p e0159316 (2016)
ISSN: 1932-6203
DOI: 10.1371/journal.pone.0159316.
Popis: Conventional efforts relying on high-throughput physical and virtual screening of large compound libraries have failed to yield high-efficiency chemical probes for many of the 48 human nuclear receptors. Here, we investigated whether disulfide-trapping, an approach new to nuclear receptors, would provide effective lead compounds targeting human liver receptor homolog 1 (hLRH-1, NR5A2). Despite the fact that hLRH-1 contains a large ligand binding pocket and binds phospholipids with high affinity, existing synthetic hLRH-1 ligands are of limited utility due to poor solubility, low efficacy or significant off-target effects. Using disulfide-trapping, we identified a lead compound that conjugates with remarkably high-efficiency to a native cysteine residue (Cys346) lining the hydrophobic cavity in the ligand binding domain of hLRH-1. Guided by computational modeling and cellular assays, the lead compound was elaborated into ligands PME8 and PME9 that bind hLRH-1 reversibly (no cysteine reactivity) and increase hLRH-1 activity in cells. When compared with the existing hLRH-1 synthetic agonist RJW100, both PME8 and PME9 showed comparable induction of the LRH-1 dependent target gene CYP24A1 in human HepG2 cells, beginning as early as 3 h after drug treatment. The induction is specific as siRNA-mediated knock-down of hLRH-1 renders both PME8 and PME9 ineffective. These data show that PME8 and PME9 are potent activators of hLRH-1 and suggest that with further development this lead series may yield useful chemical probes for manipulating LRH-1 activity in vivo.
Databáze: OpenAIRE